Steris plc earnings miss shapes expectations ahead of August update

Steris plc posted modest revenue growth but slightly missed consensus earnings estimates in its latest quarter, leaving investors focused on the next expected update in early August and what it may signal for growth and margins.

By Thomas Clarke, Operations & Strategy desk. Reviewed on June 30, 2026 at 2:12 p.m. ET.

Steris plc (ISIN IE00BFY8C754) reported fiscal fourth quarter 2026 earnings in May that showed solid top-line growth but a small earnings-per-share miss versus Wall Street expectations, according to data compiled by MarketBeat. The company trades on the New York Stock Exchange under the ticker STE, giving US investors direct exposure to its healthcare sterilization and infection-prevention franchise.

Latest quarter sets the tone

In its fourth quarter 2026 report dated May 11, Steris delivered earnings per share of $2.83, slightly below the consensus estimate of $2.86 and underscoring tight expectations on profitability (source: MarketBeat earnings summary). Quarterly revenue rose 6.7 percent year-over-year to about $1.59 billion, reflecting continued demand for Steris systems and services even as the company came in just shy of analyst revenue expectations reported at roughly the same level.

The earnings miss of $0.03 per share is narrow in absolute terms but matters for investors who have been pricing in steady margin expansion as Steris scales its global installed base. With a trailing EPS of $7.93 and a reported price-to-earnings ratio near 26.9, the stock embeds a premium valuation that assumes mid-single-digit to high-single-digit earnings growth over the coming years, as summarized in the same MarketBeat dataset. That combination of modest revenue upside and a small EPS shortfall makes the upcoming earnings window important for confirming the longer-term growth narrative.

Forward expectations and August timing

Analysts tracked by MarketBeat currently project Steris earnings to grow about 7.7 percent next year, with EPS estimates moving from roughly $11.18 to $12.04 per share based on the compiled consensus figures. That anticipated growth path suggests Wall Street expects Steris to maintain disciplined cost control and incremental margin improvement while continuing to expand its sterilization and infection-prevention offerings across hospitals and other clinical settings.

While Steris has not yet confirmed the date of its next quarterly earnings release, the MarketBeat calendar extrapolates an estimated publication around August 5, 2026 by aligning with the company’s historical reporting pattern. For investors following US healthcare equipment names on the NYSE, that estimated August window serves as a practical planning marker for when new information on orders, backlog and segment profitability is likely to emerge. The focus until then is on whether Steris can translate its installed base and service contracts into sustained double-digit earnings power over a longer horizon, or whether incremental cost pressures will keep growth closer to the high-single-digit band.

Representative product and business model

Steris’s core business revolves around providing sterilization systems, low-temperature sterilizers, washers and infection-prevention solutions that support hospitals and healthcare facilities in maintaining patient safety. The company typically earns revenue through a combination of equipment sales, long-term service contracts, consumables and related support offerings, which together create a recurring stream of income tied to the daily operations of surgical suites, endoscopy units and other critical care environments.

Steris plc stock price snapshot

As of June 30, 2026, detailed intraday price information for Steris plc’s NYSE-listed shares was not included in the available data set from MarketBeat, which last reported a closing price of $213.21 on June 29, 2026 alongside a brief extended-hours update. In the absence of a same-day real-time quote in the sources reviewed, investors should consult a current market-data feed or brokerage platform for the latest Steris share price and trading volume on the New York Stock Exchange.

Steris plc key data

• Company: Steris plc
• ISIN: IE00BFY8C754
• Ticker: STE
• Exchange: New York Stock Exchange (NYSE)
• Price (as of June 29, 2026, 3:59 p.m. ET): $213.21 USD
• Market cap: not specified in the sources reviewed
• Sector / Industry: Health care equipment and services
• Index membership: not specified in the sources reviewed
• Next earnings date: estimated August 5, 2026 (not yet officially scheduled)

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.